Annotation Detail for CST5
Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| hsa04970 | Salivary secretion |
| Desease Name |
|---|
| PHARMACOGENOMIC |
| response to TNF antagonist treatment |
| Desease Name |
|---|
| Response to TNF antagonist treatment |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D002330 |
Carmustine |
Carmustine results in decreased expression of CST5 mRNA | decreases expression | 15980968
|
| D004958 |
Estradiol |
Estradiol affects the expression of CST5 mRNA | affects expression | 14699072
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.18 | 11473722 |
| MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.89 | 16187019 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.10 | 12948864 16675129 19861407 17261762 18497071 14630087 17289903 17018787 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.35 | 16111702 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.80 | 16924424 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
3.09 | 18566989 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.88 | 19279558 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.28 | 19148513 11473722 18566989 |
| MESH:D005909 |
Glioblastoma |
|
Carmustine |
4.22 | 16187019 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
6.10 | 15709030 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.82 | 17088409 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.26 | 16393666 16627594 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.83 | 15618244 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.41 | 15610895 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.69 | 14659978 14716833 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.85 | 16891317 17203775 11807958 11408345 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.55 | 19453300 |
| MESH:D008545 |
Melanoma |
|
Carmustine |
2.91 | 12393984 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.66 | 16810080 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.62 | 17289903 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.32 | 11399458 16427766 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.33 | 19401270 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.44 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.01 | 16740699 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.76 | 19048282 |
| Pathway ID |
Pathway Name |
|---|
| KEGG:04970 |
Salivary secretion |
Pharmacogenomics Knowledge Base